The Discounted Cash Flow (DCF) valuation of Epizyme Inc (EPZM) is (352.16) USD. With the latest stock price at 1.47 USD, the upside of Epizyme Inc based on DCF is -24056.2%.
Based on the latest price of 1.47 USD and our DCF valuation, Epizyme Inc (EPZM) is a sell. selling EPZM stocks now will result in a potential gain of 24056.2%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.7% - 9.0% | 7.9% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (763.33) - (231.81) | (352.16) |
| Upside | -52027.4% - -15869.3% | -24056.2% |